Healthcare stocks were putting up strong gains Wednesday afternoon, with the NYSE Health Care Index advancing 1.9% and the SPDR Health Care Select Sector ETF (XLV) gaining 2.0%. The iShares Biotechnology ETF (IBB) also was climbing 2.9%.
In company news, Aeglea BioTherapeutics (AGLE) slumped more than 65% Wednesday after saying Jeffrey Goldberg, the former chief executive at privately held Immunitas Therapeutics, joined the company Tuesday as its new CEO, succeeding Aeglea general counsel Jim Kastenmayer, who had been its interim CEO.